[go: up one dir, main page]

WO2010062034A3 - Composition pharmaceutique de type goutte ophtalmique ou gel contenant de l'extrait de graine de vitis vinifera - Google Patents

Composition pharmaceutique de type goutte ophtalmique ou gel contenant de l'extrait de graine de vitis vinifera Download PDF

Info

Publication number
WO2010062034A3
WO2010062034A3 PCT/KR2009/005750 KR2009005750W WO2010062034A3 WO 2010062034 A3 WO2010062034 A3 WO 2010062034A3 KR 2009005750 W KR2009005750 W KR 2009005750W WO 2010062034 A3 WO2010062034 A3 WO 2010062034A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
eye drop
seed extract
gel type
vitis vinifera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/005750
Other languages
English (en)
Korean (ko)
Other versions
WO2010062034A2 (fr
Inventor
박세완
이근혁
류종현
김재신
박진하
곽은영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanlim Pharmaceutical Co Ltd
Original Assignee
Hanlim Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanlim Pharmaceutical Co Ltd filed Critical Hanlim Pharmaceutical Co Ltd
Publication of WO2010062034A2 publication Critical patent/WO2010062034A2/fr
Publication of WO2010062034A3 publication Critical patent/WO2010062034A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition pharmaceutique de type goutte ophtalmique ou gel contenant de l'extrait de graine de vitis vinifera; et un antioxydant sélectionné dans le groupe comprenant acide ascorbique ou un sel de celui-ci, hydrogènosulfite de sodium, pyrosulfite de potassium, et L-thréonine ou un sel de celle-ci. La composition pharmaceutique selon la présente invention maintient une stabilité physique et chimique pendant une longue durée. La composition pharmaceutique de l'invention peut ainsi être stockée pendant une longue durée et être utilisée de manière avantageuse dans le domaine de la fabrication de médicaments.
PCT/KR2009/005750 2008-11-28 2009-10-08 Composition pharmaceutique de type goutte ophtalmique ou gel contenant de l'extrait de graine de vitis vinifera Ceased WO2010062034A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080119366A KR101047356B1 (ko) 2008-11-28 2008-11-28 유럽종 포도의 씨 추출물을 함유하는 점안용 액제 또는 겔제 형태의 약학 조성물
KR10-2008-0119366 2008-11-28

Publications (2)

Publication Number Publication Date
WO2010062034A2 WO2010062034A2 (fr) 2010-06-03
WO2010062034A3 true WO2010062034A3 (fr) 2010-08-19

Family

ID=42226198

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/005750 Ceased WO2010062034A2 (fr) 2008-11-28 2009-10-08 Composition pharmaceutique de type goutte ophtalmique ou gel contenant de l'extrait de graine de vitis vinifera

Country Status (2)

Country Link
KR (1) KR101047356B1 (fr)
WO (1) WO2010062034A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100281477B1 (ko) * 1992-05-11 2001-02-01 팔리안티 쥬세뻬 안토시아노사이드를 함유하는 경구용 약제학적 조성물
WO2003086442A2 (fr) * 2002-04-04 2003-10-23 Natural Disinfectant Technologies Preparations ophtalmiques, pharmaceutiques et de soins de sante contenant des composes, des extraits et des derives naturels d'origine vegetale
WO2007127844A2 (fr) * 2006-04-28 2007-11-08 Alcon, Inc. Formules contenant des dérivés amides d'ains de type acide carboxylique pour administration locale au niveau de l'œil
WO2008007244A2 (fr) * 2006-06-08 2008-01-17 The Iams Company Compositions pour améliorer la santé oculaire

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100281477B1 (ko) * 1992-05-11 2001-02-01 팔리안티 쥬세뻬 안토시아노사이드를 함유하는 경구용 약제학적 조성물
WO2003086442A2 (fr) * 2002-04-04 2003-10-23 Natural Disinfectant Technologies Preparations ophtalmiques, pharmaceutiques et de soins de sante contenant des composes, des extraits et des derives naturels d'origine vegetale
WO2007127844A2 (fr) * 2006-04-28 2007-11-08 Alcon, Inc. Formules contenant des dérivés amides d'ains de type acide carboxylique pour administration locale au niveau de l'œil
WO2008007244A2 (fr) * 2006-06-08 2008-01-17 The Iams Company Compositions pour améliorer la santé oculaire

Also Published As

Publication number Publication date
KR20100060673A (ko) 2010-06-07
WO2010062034A2 (fr) 2010-06-03
KR101047356B1 (ko) 2011-07-07

Similar Documents

Publication Publication Date Title
BR112014009031A2 (pt) formulações de etanercept estabilizadas com íons de metais
WO2012153193A3 (fr) Conjugués protéine-principe actif et leur procédé de préparation
MX2009011165A (es) Formulaciones farmaceuticas que contienen derivados del acido lipoico.
EA028156B9 (ru) Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
EA201170958A1 (ru) Твердая фармацевтическая композиция, содержащая амлодипин и лозартан, и способ ее получения
EP2486793A3 (fr) Formulations d'acide S-(+)-abscissique sous forme de liquide ou de granulé soluble
WO2008132229A3 (fr) Solutions et compositions hautement concentrées en insuline
TW200833351A (en) New cosmetic and/or pharmaceutical compositions and their applications
MY157582A (en) Medical composition containing rebamipipe
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
ZA202210899B (en) Solutons for increasing the stability and shelf life of an organ and tissue preservation solution
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
WO2010025859A3 (fr) Stabilisation de cellules au moyen de liquides ioniques
WO2010056527A3 (fr) Composés hétérocycliques condensés en tant que modulateurs de canaux ioniques
GEP20135859B (en) Stable combined pharmaceutical composition
WO2008065282A3 (fr) Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation
WO2009129208A8 (fr) Compositions et procédés permettant d'induire une réponse au stress du réticulum endoplasmique
WO2012033390A3 (fr) Nouveau dérivé du thiophène utilisé comme inhibiteur du sglt2 et composition pharmaceutique comprenant ce dérivé
EA201001353A1 (ru) Гидробромид ивабрадина
IN2015DN02596A (fr)
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
WO2010062034A3 (fr) Composition pharmaceutique de type goutte ophtalmique ou gel contenant de l'extrait de graine de vitis vinifera
EA201300882A1 (ru) Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс (варианты), набор и лекарственное средство
WO2011041609A3 (fr) Formulations topiques
WO2010075086A3 (fr) Inhibiteurs de type pyrrolidinone de pde-4

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09829241

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09829241

Country of ref document: EP

Kind code of ref document: A2